{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:52:05Z","timestamp":1764852725243,"version":"3.46.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":149,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100517","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:51:33Z","timestamp":1748775093000},"page":"100517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah\u2019s Witness using chemotherapy free regimen: A case report and review of literature"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6256-5213","authenticated-orcid":false,"given":"Muhammad Hassan","family":"Raza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiraj","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis M","family":"Desjarlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lrr.2025.100517_bib0036","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1111\/jth.15074","article-title":"Management of hemostatic complications in acute leukemia: guidance from the SSC of the ISTH","volume":"18","author":"Wang","year":"2020","journal-title":"J. Thrombosis Haemost. : JTH"},{"key":"10.1016\/j.lrr.2025.100517_bib0010","doi-asserted-by":"crossref","unstructured":"Dezern, A.E., K. Williams, M. Zahurak, W. Hand, R. Scott Stephens, K.E. King, S.M. Frank, and P.M. Ness. 2016. \u201cOriginal Research\u201d 00: 1\u20138. https:\/\/doi.org\/10.1111\/trf.13658.","DOI":"10.1111\/trf.13658"},{"issue":"5","key":"10.1016\/j.lrr.2025.100517_bib0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus surgical case report (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int. J. Surg"},{"key":"10.1016\/j.lrr.2025.100517_bib0013","unstructured":"Government, US. 2023. \u201cHow Many of Jehovah\u2019s Witnesses Are There Worldwide?\u201d https:\/\/www.jw.org\/en\/jehovahs-witnesses\/faq\/how-many-jw\/."},{"issue":"2","key":"10.1016\/j.lrr.2025.100517_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tmrv.2003.12.004","article-title":"Meeting the clinical challenge of care for Jehovah\u2019s Witnesses","volume":"18","author":"Bodnaruk","year":"2004","journal-title":"Transfus Med. Rev."},{"issue":"1","key":"10.1016\/j.lrr.2025.100517_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/asheducation-2005.1.131","article-title":"Acute lymphoblastic leukemia: older patients and newer drugs","volume":"2005","author":"Larson","year":"2005","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/j.lrr.2025.100517_bib0006","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjh.16284","article-title":"Treatment of acute leukaemia in adult Jehovah\u2019s Witnesses","volume":"190","author":"Chaer","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"Suppl 3","key":"10.1016\/j.lrr.2025.100517_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.2011-S3-3","article-title":"Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management","volume":"16","author":"Hofmann","year":"2011","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.lrr.2025.100517_bib0021","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/trf.14006","article-title":"Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals","volume":"57","author":"Leahy","year":"2017","journal-title":"Transfusion (Paris)"},{"issue":"8","key":"10.1016\/j.lrr.2025.100517_bib0031","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood.V95.8.2530","article-title":"A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia","volume":"95","author":"Schiffer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100517_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12656","article-title":"Twenty-five million liters of blood into the sewer","author":"Levi","year":"2014","journal-title":"J. Thrombosis Haemostasis : JTH. England"},{"issue":"8","key":"10.1016\/j.lrr.2025.100517_bib0005","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1182\/bloodadvances.2018030387","article-title":"Management of Cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update","volume":"3","author":"Bohlius","year":"2019","journal-title":"Blood Adv."},{"issue":"7","key":"10.1016\/j.lrr.2025.100517_bib0011","doi-asserted-by":"crossref","first-page":"1561\u20141567","DOI":"10.1111\/j.1537-2995.2010.02603.x","article-title":"Management of acute anemia in a Jehovah\u2019s Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature","volume":"50","author":"Donahue","year":"2010","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.lrr.2025.100517_bib0032","doi-asserted-by":"crossref","unstructured":"Sciencedirect, Sciverse. 2013. \u201cLeukemia Research Reports\u201d 2 (February): 29\u201331. https:\/\/doi.org\/10.1016\/j.lrr.2024.100474.","DOI":"10.1016\/j.lrr.2024.100474"},{"key":"10.1016\/j.lrr.2025.100517_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/stem.5530160728","article-title":"Opportunities for the use of thrombopoietic growth factors","volume":"16","author":"Schiffer","year":"1998","journal-title":"STEM CELLS"},{"issue":"1","key":"10.1016\/j.lrr.2025.100517_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226497","article-title":"Use of Platelet and Erythroid Growth Factors during Induction Chemotherapy for Acute Lymphoblastic Leukaemia in a Jehovah\u2019s Witness","volume":"11","author":"Arora","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.lrr.2025.100517_bib0007","article-title":"Management of philadelphia chromosome-positive acute lymphoblastic leukemia in a Jehovah\u2019s Witness in an outpatient setting: a case report","volume":"4","author":"Chen","year":"2021","journal-title":"Current Problems in Cancer: Case Reports"},{"key":"10.1016\/j.lrr.2025.100517_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/trf.13703","article-title":"Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah\u2019s Witness patient","author":"Chojnowski","year":"2016","journal-title":"Transfusion (Paris). United States"},{"issue":"4","key":"10.1016\/j.lrr.2025.100517_bib0009","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1365-2141.1998.00634.x","article-title":"Acute leukaemia in Jehovah\u2019s Witnesses","volume":"100","author":"Cullis","year":"1998","journal-title":"Br. J. Haematol."},{"issue":"May","key":"10.1016\/j.lrr.2025.100517_bib0019","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.0902-4441.2003.00211.x","article-title":"Tailored therapy of adult acute leukaemia in Jehovah\u2019s Witnesses: unjustified Reluctance to Treat","volume":"72","author":"Laszlo","year":"2004","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100517_bib0024","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ajh.2830430225","article-title":"Jehovah\u2019s Witnesses and acute leukemia","volume":"43","author":"Nousiainen","year":"1993","journal-title":"Am. j. hematol."},{"key":"10.1016\/j.lrr.2025.100517_bib0026","doi-asserted-by":"crossref","DOI":"10.1080\/10428194.2019.1577414","article-title":"High-dose chemotherapy without transfusion for philadelphia chromosome negative b-cell acute lymphoblastic leukemia in two Jehovah\u2019s Witnesses patients: a feasible option in the age of hematopoietic growth factors","author":"Perol","year":"2019","journal-title":"Leuk. Lymphoma. United States"},{"issue":"3","key":"10.1016\/j.lrr.2025.100517_bib0037","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","article-title":"High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase ii study by the japan adult leukemia study group","volume":"24","author":"Yanada","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2025.100517_bib0038","article-title":"Acute lymphoblastic leukaemia in a Jehovah\u2019s Witness: a management dilemma","volume":"26","author":"Zhou","year":"2013","journal-title":"J. Chemother"},{"issue":"June","key":"10.1016\/j.lrr.2025.100517_bib0023","article-title":"The treatment of acute lymphoblastic leukemia in Jehovah\u2019s Witnesses and patients who cannot accept blood products","volume":"18","author":"Nguyen","year":"2022","journal-title":"Leuk Res. Rep."},{"key":"10.1016\/j.lrr.2025.100517_bib0001","doi-asserted-by":"crossref","unstructured":"M. Vignetti, P. Fazi, G. Cimino, G. Martinelli, F. Di Raimondo, F. Ferrara, et al., Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome\u2013positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. Blood 2007; 109 (9): 3676\u20133678. 10.1182\/blood-2006-10-052746.","DOI":"10.1182\/blood-2006-10-052746"},{"issue":"25","key":"10.1016\/j.lrr.2025.100517_bib0012","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1182\/blood-2011-05-351403","article-title":"Dasatinib as first-line treatment for adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"118","author":"Fo\u00e0","year":"2011","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.lrr.2025.100517_bib0003","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2010.28.1287","article-title":"Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia: northern italy leukemia group Protocol 09\/00","volume":"28","author":"Bassan","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lrr.2025.100517_bib0017","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","article-title":"Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study","volume":"109","author":"Labarthe","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.lrr.2025.100517_bib0025","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/cncr.22631","article-title":"Imatinib compared with chemotherapy as front-line treatment of elderly patients with philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)","volume":"109","author":"Ottmann","year":"2007","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.lrr.2025.100517_bib0027","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2009-12-261586","article-title":"First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with philadelphia chromosome-positive (Ph+) acute lymphoblastic Leukemia","volume":"116","author":"Ravandi","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lrr.2025.100517_bib0029","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1182\/blood-2016-02-700153","article-title":"Dasatinib and low-intensity chemotherapy in elderly patients with philadelphia chromosome-positive ALL","volume":"128","author":"Rousselot","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100517_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2009.011221","article-title":"Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 Trial","volume":"95","author":"Ribera","year":"2010","journal-title":"Haematologica"},{"issue":"Supplement 1","key":"10.1016\/j.lrr.2025.100517_bib0033","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1182\/blood-2021-153795","article-title":"Updated results of a phase II study of ponatinib and blinatumomab for patients with philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"138","author":"Short","year":"2021","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.lrr.2025.100517_bib0014","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood-2023-188064","article-title":"Chemotherapy-free combination of blinatumomab and ponatinib in adults with newly diagnosed philadelphia chromosome-positive acute lymphoblastic leukemia: updates from a phase II trial","volume":"142","author":"Haddad","year":"2023","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.lrr.2025.100517_bib0034","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood-2022-157775","article-title":"Ponatinib and blinatumomab for patients with newly diagnosed philadelphia chromosome-positive acute lymphoblastic leukemia: a subgroup analysis from a phase II study","volume":"140","author":"Short","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2025.100517_bib0016","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2352-3026(22)00319-2","article-title":"Ponatinib and blinatumomab for philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, Single-Centre, Single-Arm, Phase 2 Trial","volume":"10","author":"Jabbour","year":"2023","journal-title":"Lancet Haematol"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:48:19Z","timestamp":1764852499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048925000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"alternative-id":["S2213048925000196"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100517","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah\u2019s Witness using chemotherapy free regimen: A case report and review of literature","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100517"}}